Dec 18, 2022
And today there's a scandalous new story out about the staggering prices a drug company is charging for a new med for Lou Gehrig's disease.
Written by Janice Harayda
Critic, novelist, award-winning journalist. Former book editor of the Plain Dealer and book columnist for Glamour. Words in NYT, WSJ, and other major media.